JP2006511474A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511474A5 JP2006511474A5 JP2004537682A JP2004537682A JP2006511474A5 JP 2006511474 A5 JP2006511474 A5 JP 2006511474A5 JP 2004537682 A JP2004537682 A JP 2004537682A JP 2004537682 A JP2004537682 A JP 2004537682A JP 2006511474 A5 JP2006511474 A5 JP 2006511474A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenoxy
- butylamino
- nicotinamide
- pyrazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ADXBHKREPBWTDP-UHFFFAOYSA-N CC(C)CCNCc(cc1)ccc1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(cc1)ccc1Oc(cc1)ncc1C(N)=O ADXBHKREPBWTDP-UHFFFAOYSA-N 0.000 description 4
- QWNDOCKIKKQJNN-UHFFFAOYSA-N NC(c(cc1)cnc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O Chemical compound NC(c(cc1)cnc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O QWNDOCKIKKQJNN-UHFFFAOYSA-N 0.000 description 3
- WSTRRHWTLHPFLJ-UHFFFAOYSA-N CC(C)(C)CCNCc(cc1F)ccc1Oc1ncc(C(N)=O)nc1 Chemical compound CC(C)(C)CCNCc(cc1F)ccc1Oc1ncc(C(N)=O)nc1 WSTRRHWTLHPFLJ-UHFFFAOYSA-N 0.000 description 2
- QWVMKVCQRJKDNE-UHFFFAOYSA-N CC(C)CCNCc(c(F)c1F)cc(F)c1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(c(F)c1F)cc(F)c1Oc(cc1)ncc1C(N)=O QWVMKVCQRJKDNE-UHFFFAOYSA-N 0.000 description 2
- KXIFIKGCMNZIRR-UHFFFAOYSA-N CCCCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CCCCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O KXIFIKGCMNZIRR-UHFFFAOYSA-N 0.000 description 2
- ZGCYVRNZWGUXNQ-UHFFFAOYSA-N COc1cc(CNCCC2CCOCC2)ccc1Oc(nc1)cnc1C(N)=O Chemical compound COc1cc(CNCCC2CCOCC2)ccc1Oc(nc1)cnc1C(N)=O ZGCYVRNZWGUXNQ-UHFFFAOYSA-N 0.000 description 2
- ORJMHMIAJUKSME-UHFFFAOYSA-N COc1cc(CNCCc(cc2)ccc2F)ccc1Oc(nc1)cnc1C(N)=O Chemical compound COc1cc(CNCCc(cc2)ccc2F)ccc1Oc(nc1)cnc1C(N)=O ORJMHMIAJUKSME-UHFFFAOYSA-N 0.000 description 2
- SRTJWEAYPLHPFJ-UHFFFAOYSA-N CC(C)(C)CCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CC(C)(C)CCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O SRTJWEAYPLHPFJ-UHFFFAOYSA-N 0.000 description 1
- MPAAEZPHTFLIIG-UHFFFAOYSA-N CC(C)(C)CCNCCc(cc1F)cc(F)c1Oc(nc1)ccc1C(N)=O Chemical compound CC(C)(C)CCNCCc(cc1F)cc(F)c1Oc(nc1)ccc1C(N)=O MPAAEZPHTFLIIG-UHFFFAOYSA-N 0.000 description 1
- RTJRBLXYTFNKGI-UHFFFAOYSA-N CC(C)(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1Cl Chemical compound CC(C)(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1Cl RTJRBLXYTFNKGI-UHFFFAOYSA-N 0.000 description 1
- WGCYEUMXKPHFPH-UHFFFAOYSA-N CC(C)(C)CCNCc(cc1F)cc(OC)c1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)(C)CCNCc(cc1F)cc(OC)c1Oc(cc1)ncc1C(N)=O WGCYEUMXKPHFPH-UHFFFAOYSA-N 0.000 description 1
- MXOQKGNZONURBF-UHFFFAOYSA-N CC(C)CCNCc(cc1)ccc1Oc(c(F)cc(C(N)=O)c1)c1F Chemical compound CC(C)CCNCc(cc1)ccc1Oc(c(F)cc(C(N)=O)c1)c1F MXOQKGNZONURBF-UHFFFAOYSA-N 0.000 description 1
- IBNFHMRDGWKDCH-UHFFFAOYSA-N CC(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1F Chemical compound CC(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1F IBNFHMRDGWKDCH-UHFFFAOYSA-N 0.000 description 1
- HLCRMSMJGHCCGN-UHFFFAOYSA-N CC(C)CCNCc(cc1C)ccc1Oc(nc1)ccc1C(N)=O Chemical compound CC(C)CCNCc(cc1C)ccc1Oc(nc1)ccc1C(N)=O HLCRMSMJGHCCGN-UHFFFAOYSA-N 0.000 description 1
- WKJOLNYSGNKXFN-UHFFFAOYSA-N CC(C)CCNCc(cc1Cl)ccc1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(cc1Cl)ccc1Oc(cc1)ncc1C(N)=O WKJOLNYSGNKXFN-UHFFFAOYSA-N 0.000 description 1
- DZZIJHPOQGYOHW-UHFFFAOYSA-N CC(C)CCNCc(cc1F)cc(F)c1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(cc1F)cc(F)c1Oc(cc1)ncc1C(N)=O DZZIJHPOQGYOHW-UHFFFAOYSA-N 0.000 description 1
- KBJFPTRVYNXNLR-UHFFFAOYSA-N CC(C)CCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CC(C)CCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O KBJFPTRVYNXNLR-UHFFFAOYSA-N 0.000 description 1
- COOCONHDRCJRDK-UHFFFAOYSA-N CCCCCNCc(c(F)c1F)ccc1Oc(nc1)ccc1C(N)=O Chemical compound CCCCCNCc(c(F)c1F)ccc1Oc(nc1)ccc1C(N)=O COOCONHDRCJRDK-UHFFFAOYSA-N 0.000 description 1
- NYFIRDWZRSBSFQ-UHFFFAOYSA-N CCCCCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CCCCCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O NYFIRDWZRSBSFQ-UHFFFAOYSA-N 0.000 description 1
- IHCVJFPPZBMWNV-UHFFFAOYSA-N Cc(cc(CNCCC1CCOCC1)cc1)c1Oc(nc1)cnc1C(N)=O Chemical compound Cc(cc(CNCCC1CCOCC1)cc1)c1Oc(nc1)cnc1C(N)=O IHCVJFPPZBMWNV-UHFFFAOYSA-N 0.000 description 1
- ORWSVYPVMAOKOR-UHFFFAOYSA-N NC(c(cn1)ccc1Oc1ccc(CNCCC2CCOCC2)cc1)=O Chemical compound NC(c(cn1)ccc1Oc1ccc(CNCCC2CCOCC2)cc1)=O ORWSVYPVMAOKOR-UHFFFAOYSA-N 0.000 description 1
- FESNRGIEUHAIML-UHFFFAOYSA-N NC(c(cn1)ncc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O Chemical compound NC(c(cn1)ncc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O FESNRGIEUHAIML-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41215802P | 2002-09-19 | 2002-09-19 | |
| PCT/US2003/026300 WO2004026305A1 (en) | 2002-09-19 | 2003-09-17 | Diaryl ethers as opioid receptor antagonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006511474A JP2006511474A (ja) | 2006-04-06 |
| JP2006511474A5 true JP2006511474A5 (https=) | 2006-10-19 |
| JP4646628B2 JP4646628B2 (ja) | 2011-03-09 |
Family
ID=32030816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004537682A Expired - Lifetime JP4646628B2 (ja) | 2002-09-19 | 2003-09-17 | オピオイド受容体アンタゴニストとしてのジアリールエーテル類 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US7381719B2 (https=) |
| EP (2) | EP1562595B1 (https=) |
| JP (1) | JP4646628B2 (https=) |
| KR (1) | KR101025633B1 (https=) |
| CN (1) | CN1305852C (https=) |
| AR (1) | AR042423A1 (https=) |
| AT (1) | ATE395915T1 (https=) |
| AU (1) | AU2008246245B2 (https=) |
| BR (1) | BRPI0314308B8 (https=) |
| CA (1) | CA2499690C (https=) |
| CY (2) | CY1108228T1 (https=) |
| DE (1) | DE60321207D1 (https=) |
| DK (2) | DK2208727T3 (https=) |
| EA (1) | EA008861B1 (https=) |
| EC (1) | ECSP055684A (https=) |
| ES (2) | ES2305491T3 (https=) |
| HR (1) | HRP20050253B1 (https=) |
| MX (1) | MXPA05003093A (https=) |
| MY (1) | MY140236A (https=) |
| NO (1) | NO330740B1 (https=) |
| NZ (1) | NZ538459A (https=) |
| PE (1) | PE20050080A1 (https=) |
| PL (1) | PL212616B1 (https=) |
| PT (2) | PT1562595E (https=) |
| SI (2) | SI2208727T1 (https=) |
| TW (1) | TWI287012B (https=) |
| UA (1) | UA80437C2 (https=) |
| WO (1) | WO2004026305A1 (https=) |
| ZA (1) | ZA200502276B (https=) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6374762B1 (en) * | 1997-10-27 | 2002-04-23 | Correct Craft, Inc. | Water sport towing apparatus |
| US20030170917A1 (en) * | 2002-03-01 | 2003-09-11 | Roche Diagnostics Corporation | Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| KR101025633B1 (ko) * | 2002-09-19 | 2011-03-30 | 일라이 릴리 앤드 캄파니 | 오피오이드 수용체 안타고니스트로서의 디아릴 에테르 |
| GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| KR100897642B1 (ko) * | 2002-12-20 | 2009-05-14 | 글락소 그룹 리미티드 | 신경 장애 치료용 벤즈아제핀 유도체 |
| CN1756746A (zh) * | 2003-03-07 | 2006-04-05 | 伊莱利利公司 | 作为阿片样物质受体拮抗剂的6－取代的烟酰胺衍生物 |
| KR20110140139A (ko) * | 2003-08-29 | 2011-12-30 | 오노 야꾸힝 고교 가부시키가이샤 | Ｓ１ｐ 수용체 결합능을 갖는 화합물 및 그 의약 용도 |
| US7825109B2 (en) | 2003-08-29 | 2010-11-02 | Ono Pharmaceutical Co., Ltd. | Compound capable of binding S1P receptor and pharmaceutical use thereof |
| BRPI0417156A (pt) | 2003-12-12 | 2007-03-06 | Lilly Co Eli | composto, composição farmacêutica, e, métodos para bloquear receptor mu, capa, delta ou combinação (heterodìmero) dos mesmos em mamìferos, para tratar e/ou prevenir doenças relacionadas com obesidade e obesidade, para suprimir apetite em um paciente, para efetuar perda de peso em um paciente obeso |
| CN1894240A (zh) * | 2003-12-22 | 2007-01-10 | 伊莱利利公司 | 阿片受体拮抗剂 |
| JP4958560B2 (ja) | 2003-12-24 | 2012-06-20 | プロシディオン・リミテッド | Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体 |
| EP1730140B1 (en) | 2004-03-12 | 2008-06-25 | Eli Lilly And Company | Opioid receptor antagonists |
| EP1727788B1 (en) | 2004-03-12 | 2010-07-28 | Eli Lilly And Company | Opioid receptor antagonists |
| JP2007529523A (ja) | 2004-03-15 | 2007-10-25 | イーライ リリー アンド カンパニー | 肥満症を治療するためのオピオイド受容体拮抗物質としての４−（５−アミノメチル）−インドール−１−イルメチル）−ベンズアミド誘導体および関連化合物 |
| CA2557794A1 (en) | 2004-03-15 | 2005-10-06 | Eli Lilly And Company | Opioid receptor antagonists |
| GB0408083D0 (en) * | 2004-04-08 | 2004-05-12 | Glaxo Group Ltd | Novel compounds |
| PE20060115A1 (es) | 2004-07-23 | 2006-03-23 | Basf Ag | 2-(piridin-2-il)-pirimidinas como agentes fungicidas |
| EP2374455A3 (en) | 2004-08-19 | 2012-03-28 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| RU2007124373A (ru) * | 2004-11-29 | 2009-01-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецептеров |
| BRPI0519012A2 (pt) * | 2004-12-13 | 2008-12-23 | Ono Pharmaceutical Co | derivado do Ácido aminocarboxÍlico e seu uso medicinal |
| US20060235028A1 (en) * | 2005-04-14 | 2006-10-19 | Li James J | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| WO2007047397A2 (en) | 2005-10-13 | 2007-04-26 | Smithkline Beecham Corporation | Phenol ethers as modulators of the opioid receptors |
| WO2007067444A1 (en) | 2005-12-08 | 2007-06-14 | Millennium Pharmaceuticals, Inc. | Bicyclic compounds with kinase inhibitory activity |
| AU2006329007A1 (en) * | 2005-12-20 | 2007-06-28 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| AU2006330866A1 (en) * | 2005-12-22 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| LT1976828T (lt) | 2005-12-29 | 2017-04-25 | Celtaxsys, Inc. | Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai |
| KR20080098070A (ko) * | 2006-02-22 | 2008-11-06 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 |
| AU2007221214A1 (en) | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| BRPI0712823A2 (pt) | 2006-06-23 | 2012-07-24 | Abbott Lab | derivados de ciclopropil amina como moduladores de receptor de histamina h3 |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| CN101500565A (zh) * | 2006-06-29 | 2009-08-05 | 弗特克斯药品有限公司 | 毒蕈碱性受体的调节剂 |
| WO2008021849A2 (en) * | 2006-08-09 | 2008-02-21 | Smithkline Beecham Corporation | Novel compounds as antagonists or inverse agonists at opioid receptors |
| AU2007284548A1 (en) * | 2006-08-15 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CA2660974A1 (en) | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CN101511808A (zh) | 2006-09-08 | 2009-08-19 | 辉瑞产品公司 | 二芳基醚衍生物及其用途 |
| CN101583593A (zh) * | 2006-11-13 | 2009-11-18 | 辉瑞产品公司 | 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途 |
| US8093246B2 (en) * | 2006-12-14 | 2012-01-10 | Lexicon Pharmaceuticals, Inc. | O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer |
| IL180134A0 (en) * | 2006-12-17 | 2007-07-04 | David Ovadia | Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy -phenyl acrylate derivatives |
| US20080186971A1 (en) * | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
| WO2008142454A1 (en) * | 2007-05-22 | 2008-11-27 | Prosidion Limited | Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| WO2009030962A1 (en) | 2007-09-07 | 2009-03-12 | Prosidion Limited | Bicyclic aryl and heteroaryl receptor modulators |
| WO2009036144A1 (en) * | 2007-09-12 | 2009-03-19 | Wyeth | Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| JP2010540640A (ja) * | 2007-10-03 | 2010-12-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン作用性レセプターのモジュレーター |
| WO2009094260A1 (en) * | 2008-01-22 | 2009-07-30 | Eli Lilly And Company | Kappa selective opioid receptor antagonist |
| WO2010067233A1 (en) | 2008-12-08 | 2010-06-17 | Pfizer Inc. | 1,2,4 triazolo [4, 3 -a] [1,5] benzodiazepin-5 (6h) -ones as agonists of the cholecystokinin-1 receptor (cck-ir) |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| CA2774021A1 (en) * | 2009-09-18 | 2011-03-24 | Adolor Corporation | Use of opioid receptor antagonist for gastrointestinal tract disorders |
| WO2012064396A2 (en) | 2010-08-21 | 2012-05-18 | Georgetown University | Novel ezrin inhibitors and methods of making and using |
| WO2012037258A1 (en) | 2010-09-16 | 2012-03-22 | Abbott Laboratories | Processes for preparing 1,2-substituted cyclopropyl derivatives |
| WO2012075232A1 (en) * | 2010-12-04 | 2012-06-07 | Trevena, Inc. | Opioid receptor ligands and methods of using and making the same |
| SI2688403T1 (sl) * | 2011-03-23 | 2017-08-31 | Trevena, Inc. | Ligandi opioidnih receptorjev in metode uporabe in izdelave istega |
| GB201118876D0 (en) * | 2011-11-01 | 2011-12-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| EP2773352B1 (en) * | 2011-12-09 | 2017-06-28 | Research Triangle Institute | 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists |
| WO2013113787A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113720A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| AU2013214137A1 (en) | 2012-02-03 | 2014-08-21 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113778A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2014152536A2 (en) * | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| KR20180093930A (ko) | 2015-12-14 | 2018-08-22 | 트레베나, 인코포레이티드. | 통각과민증을 치료하는 방법 |
| CN106117190B (zh) * | 2016-06-21 | 2019-03-29 | 山东川成医药股份有限公司 | 一种倍福普兰的合成方法 |
| US10316021B2 (en) | 2016-11-28 | 2019-06-11 | Pfizer Inc. | Heteroarylphenoxy benzamide kappa opioid ligands |
| CN108299411B (zh) * | 2017-01-13 | 2021-02-05 | 中国人民解放军军事医学科学院毒物药物研究所 | 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途 |
| CN110446495B (zh) | 2017-02-17 | 2023-09-05 | 特维娜有限公司 | 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法 |
| AU2018221148B2 (en) | 2017-02-17 | 2022-05-05 | Trevena, Inc. | 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| EP3652165B1 (en) * | 2017-07-12 | 2021-08-25 | Bristol-Myers Squibb Company | Five membered-aminoheterocyclic and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure |
| WO2020039088A2 (en) * | 2018-08-24 | 2020-02-27 | Xeniopro GmbH | Novel compounds |
| TW202206429A (zh) | 2020-04-29 | 2022-02-16 | 美商迦舒布魯姆生物有限公司 | 雜環ｇｌｐ—１促效劑 |
| JP2023537501A (ja) | 2020-08-06 | 2023-09-01 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環ｇｌｐ－１アゴニスト |
| US12161622B2 (en) | 2021-05-04 | 2024-12-10 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| EP4489730B1 (en) | 2022-03-07 | 2026-01-21 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant |
| CN119156211A (zh) | 2022-03-07 | 2024-12-17 | 杨森制药公司 | 用于治疗重性抑郁障碍的多晶型形式的阿替卡普兰 |
| US20250206757A1 (en) * | 2022-03-21 | 2025-06-26 | Gasherbrum Bio, Inc. | 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes |
| WO2025122979A1 (en) * | 2023-12-07 | 2025-06-12 | Atai Therapeutics, Inc. | Compounds for serotonin receptor activation and pharmaceutical compositions and methods of using the same |
| WO2026015709A1 (en) * | 2024-07-10 | 2026-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Covalent inhibitors of jak2 jh2 domain |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191771A (en) | 1974-09-06 | 1980-03-04 | Eli Lilly And Company | Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines |
| SE417011B (sv) * | 1979-03-05 | 1981-02-16 | Saab Scania Ab | Malanordning |
| US4346091A (en) * | 1980-05-27 | 1982-08-24 | Shell Oil Company | Insecticidal combinations |
| US4659089A (en) * | 1981-09-18 | 1987-04-21 | Tvi Energy Corporation | Multi-spectral target |
| US4546983A (en) * | 1981-09-18 | 1985-10-15 | Tvi Energy Corporation | Multi-spectral target |
| US4422646A (en) * | 1981-09-18 | 1983-12-27 | Tvi Energy Corporation | Infrared target for military applications and its use |
| US4891379A (en) | 1987-04-16 | 1990-01-02 | Kabushiki Kaisha Kobe Seikosho | Piperidine opioid antagonists |
| DE3851081T2 (de) * | 1987-04-16 | 1995-02-16 | Lilly Co Eli | Piperidine als Opioid-Antagoniste. |
| US4792142A (en) * | 1987-11-13 | 1988-12-20 | Davies Robert M | Thermal target device |
| US5065032A (en) * | 1990-09-10 | 1991-11-12 | Custom Training Aids | Thermal integrated target |
| US5319213A (en) * | 1992-04-06 | 1994-06-07 | The United States Of America As Represented By The Secretary Of The Army | Thermal target test board |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| ES2171839T3 (es) * | 1996-09-05 | 2002-09-16 | Lilly Co Eli | Analogos de carbazol como agonistas adrenergicos selectivos de beta3. |
| US5969369A (en) * | 1997-08-29 | 1999-10-19 | Fogarty; Charles M. | Infrared emissive module |
| CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| SE9802209D0 (sv) * | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
| AUPP796798A0 (en) * | 1998-12-30 | 1999-01-28 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| US6436959B1 (en) * | 1998-12-23 | 2002-08-20 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)]aminobenzamides |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| US6337475B1 (en) * | 2000-02-24 | 2002-01-08 | The United States Of America As Represented By The Secretary Of The Army | Thermal silhouette target and zeroing technique |
| EP1303509B1 (en) * | 2000-07-13 | 2012-11-28 | Eli Lilly And Company | Beta3 adrenergic agonists |
| WO2002038544A2 (en) | 2000-11-10 | 2002-05-16 | Eli Lilly And Company | 3-substituted oxindole beta 3 agonists |
| US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| DK1859798T3 (en) | 2001-03-29 | 2016-03-21 | Lilly Co Eli | N- (2-arylethyl) -BENZYLAMINER as antagonists of 5-HT6 receptor |
| GB0109103D0 (en) * | 2001-04-11 | 2001-05-30 | Pfizer Ltd | Novel compounds |
| KR101025633B1 (ko) * | 2002-09-19 | 2011-03-30 | 일라이 릴리 앤드 캄파니 | 오피오이드 수용체 안타고니스트로서의 디아릴 에테르 |
| CN1756746A (zh) * | 2003-03-07 | 2006-04-05 | 伊莱利利公司 | 作为阿片样物质受体拮抗剂的6－取代的烟酰胺衍生物 |
| US7396943B2 (en) * | 2003-03-07 | 2008-07-08 | Eli Lilly And Company | Opioid receptor antagonists |
| US6767015B1 (en) * | 2003-06-05 | 2004-07-27 | The United States Of America As Represented By The Secretary Of The Navy | Thermal target |
| BRPI0417156A (pt) * | 2003-12-12 | 2007-03-06 | Lilly Co Eli | composto, composição farmacêutica, e, métodos para bloquear receptor mu, capa, delta ou combinação (heterodìmero) dos mesmos em mamìferos, para tratar e/ou prevenir doenças relacionadas com obesidade e obesidade, para suprimir apetite em um paciente, para efetuar perda de peso em um paciente obeso |
| CN1894240A (zh) * | 2003-12-22 | 2007-01-10 | 伊莱利利公司 | 阿片受体拮抗剂 |
| EP1730140B1 (en) * | 2004-03-12 | 2008-06-25 | Eli Lilly And Company | Opioid receptor antagonists |
| EP1727788B1 (en) * | 2004-03-12 | 2010-07-28 | Eli Lilly And Company | Opioid receptor antagonists |
| JP2007529523A (ja) * | 2004-03-15 | 2007-10-25 | イーライ リリー アンド カンパニー | 肥満症を治療するためのオピオイド受容体拮抗物質としての４−（５−アミノメチル）−インドール−１−イルメチル）−ベンズアミド誘導体および関連化合物 |
| CA2557794A1 (en) * | 2004-03-15 | 2005-10-06 | Eli Lilly And Company | Opioid receptor antagonists |
-
2003
- 2003-09-17 KR KR1020057004628A patent/KR101025633B1/ko not_active Expired - Lifetime
- 2003-09-17 CN CNB038222418A patent/CN1305852C/zh not_active Expired - Lifetime
- 2003-09-17 DK DK08153866.2T patent/DK2208727T3/da active
- 2003-09-17 MY MYPI20033546A patent/MY140236A/en unknown
- 2003-09-17 NZ NZ538459A patent/NZ538459A/en not_active IP Right Cessation
- 2003-09-17 DK DK03751877T patent/DK1562595T3/da active
- 2003-09-17 WO PCT/US2003/026300 patent/WO2004026305A1/en not_active Ceased
- 2003-09-17 DE DE60321207T patent/DE60321207D1/de not_active Expired - Lifetime
- 2003-09-17 AR ARP030103376A patent/AR042423A1/es active IP Right Grant
- 2003-09-17 JP JP2004537682A patent/JP4646628B2/ja not_active Expired - Lifetime
- 2003-09-17 ES ES03751877T patent/ES2305491T3/es not_active Expired - Lifetime
- 2003-09-17 US US10/526,960 patent/US7381719B2/en not_active Expired - Lifetime
- 2003-09-17 BR BRPI0314308A patent/BRPI0314308B8/pt not_active IP Right Cessation
- 2003-09-17 EP EP03751877A patent/EP1562595B1/en not_active Expired - Lifetime
- 2003-09-17 SI SI200332196T patent/SI2208727T1/sl unknown
- 2003-09-17 EP EP08153866A patent/EP2208727B1/en not_active Expired - Lifetime
- 2003-09-17 MX MXPA05003093A patent/MXPA05003093A/es active IP Right Grant
- 2003-09-17 PT PT03751877T patent/PT1562595E/pt unknown
- 2003-09-17 EA EA200500508A patent/EA008861B1/ru unknown
- 2003-09-17 PT PT08153866T patent/PT2208727E/pt unknown
- 2003-09-17 ES ES08153866T patent/ES2392200T3/es not_active Expired - Lifetime
- 2003-09-17 HR HRP20050253AA patent/HRP20050253B1/hr not_active IP Right Cessation
- 2003-09-17 PL PL376057A patent/PL212616B1/pl unknown
- 2003-09-17 SI SI200331282T patent/SI1562595T1/sl unknown
- 2003-09-17 AT AT03751877T patent/ATE395915T1/de active
- 2003-09-17 UA UAA200502384A patent/UA80437C2/uk unknown
- 2003-09-17 CA CA2499690A patent/CA2499690C/en not_active Expired - Lifetime
- 2003-09-18 TW TW092125729A patent/TWI287012B/zh not_active IP Right Cessation
- 2003-09-18 PE PE2003000959A patent/PE20050080A1/es active IP Right Grant
-
2005
- 2005-03-17 ZA ZA200502276A patent/ZA200502276B/en unknown
- 2005-03-17 EC EC2005005684A patent/ECSP055684A/es unknown
- 2005-04-18 NO NO20051871A patent/NO330740B1/no not_active IP Right Cessation
-
2008
- 2008-03-21 US US12/052,994 patent/US7560463B2/en not_active Expired - Lifetime
- 2008-03-21 US US12/052,972 patent/US7531557B2/en not_active Expired - Lifetime
- 2008-07-30 CY CY20081100798T patent/CY1108228T1/el unknown
- 2008-11-19 AU AU2008246245A patent/AU2008246245B2/en not_active Expired
-
2012
- 2012-10-25 CY CY20121101016T patent/CY1113362T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511474A5 (https=) | ||
| CA2533598C (en) | Method for modulating calcium ion-release-activated calcium ion channels | |
| CA2299139A1 (en) | 4-phenyl-pyridine derivatives | |
| JP2004529931A5 (https=) | ||
| JP2010530432A5 (https=) | ||
| HRP20120029T1 (hr) | Derivati (4(4-[6-trifluorometil-piridin-3-ilamino)-n-sadržavajući-heteroaril]-fenil)-cikloheksil)-octene kiseline i njihove farmaceutske uporabe | |
| JP2019531320A5 (https=) | ||
| JP2004504301A5 (https=) | ||
| JP2008007519A5 (https=) | ||
| ZA200502276B (en) | Diaryl ethers as opioid receptor antagonist | |
| TW200815422A (en) | Heteroaryl derivatives as cytokine inhibitors | |
| JP2016534124A5 (https=) | ||
| JP2009516685A5 (https=) | ||
| RU2004135539A (ru) | Производные фенилалкановых кислот и фенилоксиалкановых кислот как активаторы hppar | |
| JP2009500443A5 (https=) | ||
| JP2004504400A5 (https=) | ||
| CA2475708A1 (en) | Nicotinamide derivatives useful as pde4 inhibitors | |
| RU2012134093A (ru) | 4-фенокси-никотинамиды или 4-фенокси-пиримидин-5-карбоксамиды | |
| Hinklin et al. | Identification of a new class of glucokinase activators through structure-based design | |
| JP2005514432A5 (https=) | ||
| CN115955968A (zh) | 包含通过新型接头连接的至少两种芳基或杂芳基的碳腙酰二腈化合物及其用途 | |
| CN103102348A (zh) | 噁二唑类化合物及其制备方法、药物组合物及其用途 | |
| CA2582276A1 (en) | Alkil-pyridines as 11-beta inhibitors for diabetes | |
| ME01851B (me) | Amidni derivati koji nose ciklopropilaminokarbonilni supstituent korisni kao inhibitori citokina | |
| CN101389610A (zh) | 作为香草素受体1(vr1)抑制剂的新苯并咪唑衍生物 |